Hyperthermic Intraoperative Intraperitoneal Chemotherapy for Intra-abdominally Advanced Colorectal, Appendix, Gastric, Small Bowel, Primary Peritoneal, Ovarian Cancers, Peritoneal Mesothelioma, and Sarcomas

Topic of Study: Other

Principal Investigator: Armando Sardi, M.D. and Vadim Gushchin, M.D., 410-332-9294

Research Coordinator: Mary Caitlin King, 410-332-9294

For More Information: 410-332-9294

Coordinated Through: Surgical Oncology at Mercy

This study involves storing specimens from CRS/HIPEC patients with advanced colorectal, gastric, small bowel, primary peritoneal, ovarian cancers, peritoneal mesothelioma, and sarcomas. The purpose is to collect, maintain, and store tissues specimens from CRS/HIPEC and clinical data for future research. The collection of clinical data and outcomes from CRS/HIPEC for advanced intra-abdominal cancers will be used to refine future treatment protocols and enhance patient care